AMGN : Analysis & Opinions

  1. AMCPX: American Funds AMCAP Portfolio Top 5 Holdings Analysis ...

    May 7, 2016
    Discover the American Funds AMCAP Fund, a large-cap growth fund that seeks stocks with attractive valuations and long-term ...
  2. CWGIX: American Funds Capital World Growth and Income Top 5 Holdings

    May 6, 2016
    Discover which companies comprise the top five holdings of the American Funds Capital World Growth and Income A Fund, and ...
  3. AIVSX: American Funds Investment Company Performance Case Study

    May 4, 2016
    Learn more about American Funds Investment Company of America mutual fund including fund history, asset holding composition, ...
  4. CAIBX: American Funds Capital Income Builder Top 5 Holdings Analysis

    May 3, 2016
    Discover the top five equity holdings of American Funds' Capital Income Builders fund, a world asset allocation fund that ...
  5. AMCPX: American Funds AMCAP Fund Performance Case Study

    April 29, 2016
    Explore the market-beating performance of the American Funds AMCAP Fund, including the seasonal patterns when buying and ...
  6. The 3 Largest Health Care ETFs (XLV, IBB)

    April 25, 2016
    Find out which exchange-traded funds (ETFs) are the largest in terms of total assets under management (AUM) in the health ...
  7. CAIBX: American Funds Capital Income Builder Trends in 2016

    April 15, 2016
    Learn about the composition of the American Funds Capital Income Builder fund, and discover how its makeup has evolved between ...
  8. FSPHX: Fidelity Select Healthcare Fund's Top 5 Holdings Analysis

    April 6, 2016
    Learn about the top five holdings in the four-star rated Fidelity Select Health Care fund, managed by top portfolio manager, ...
  9. AIVSX: American Funds I.C. of America Top 5 Holdings Analysis

    March 31, 2016
    Learn about the top-five holdings of The Investment Company of America, one of the nation's oldest equity mutual funds with ...
  10. AIVSX: Portfolio Trends in 2016

    March 23, 2016
    Discover the year-over-year portfolio trends in the American Funds Investment Company of America and learn if the 82-year-old ...
  11. CWGIX: Overview of American Funds Capital World Growth & Income ...

    March 20, 2016
    Learn about the American Funds Capital World Growth and Income Fund, a world stock fund that seeks quality stocks on any ...
  12. (VHT) Vanguard Healthcare ETF: Top 5 Holdings

    March 19, 2016
    Identify the top five holdings in the Vanguard Health Care exchange-traded fund (ETF), and evaluate each holding's business ...
  13. AMCPX: Overview of American Funds AMCAP Fund

    March 19, 2016
    Learn about the American Funds Amcap Fund, a large-cap growth fund from Capital Group, which is one of the nation's most ...
  14. 4 Defensive ETFs Worth Your While (VHT, PGX)

    March 19, 2016
    Find out which top exchange-traded funds (ETFs) would be well worth your consideration when deploying a defensive investment ...
  15. AIVSX: Overview of Investment Company of America Fund

    March 18, 2016
    Discover the American Funds Investment Company of America, a growth and income fund with an 80-plus-year history of providing ...
  16. (IBB) iShares NASDAQ Biotech SPDR ETF: Top 5 Holdings

    March 16, 2016
    Take a close look at the strong fundamentals underlying the top five holdings of the iShares NASDAQBiotechnology ETF as it ...
  17. Analyzing Amgen's Debt Ratios in 2016 (AMGN)

    February 29, 2016
    Learn about Amgen Inc. and its key debt ratios, such as the debt-to-equity ratio, interest coverage ratio and cash flow-to-debt ...
  18. Amgen: An Activist Investment Analysis (AMGN)

    February 26, 2016
    Learn about the activist investor campaign Third Point Partners has initiated against Amgen. Read about Third Point's criticisms ...
  19. Analyzing Amgen's Price & Profitability Ratios in 2016 (AMGN)

    February 26, 2016
    Learn about Amgen's price ratios and profitability ratios and discover why it has one of the highest profit margins in the ...
  20. Are These the Top Biotech Stocks of 2016?

    January 19, 2016
    These three biotech stocks are likely hold up better than their peers in 2016.
  21. The Top 10 Healthcare Stocks for 2016 (ABT, AGN)

    January 6, 2016
    Learn about the top 10 health care stocks expected to grow in 2016, with brief insights into each company's growth potential ...
  22. The Top 4 Dividend Paying Biotechnology Stocks for 2016 (AMGN, ...

    January 5, 2016
    Discover the top four dividend-bearing biotech stocks for 2016, including one undervalued stock trading at bargain-basement ...
  23. The Top 5 Large Cap Biotechnology Stocks for 2016 (AMGN, BIIB)

    January 5, 2016
    Discover the top five biotechnology stocks for 2016. Learn each company's main revenue drivers and what factors cause their ...
  24. The Top 3 Biotechnology Stocks for 2016 (AMGN, VRX)

    December 30, 2015
    Find out more about the top three biotechnology stocks to consider in 2016, and learn about their characteristics and why ...
  25. 3 Biotech Blue-Chip Companies to Keep an Eye On (AMGN, BIIB)

    December 23, 2015
    Discover three blue-chip biotech stocks you should keep your eye on in 2016. Despite recent struggles in the industry, these ...
  26. The World's Top 10 Biotechnology Companies (JNJ, ROG.VX)

    December 22, 2015
    Learn how the marriage of science and technology is changing the world of medicine and creating some of the largest multinational ...
  27. The Top 5 Dividend Paying Healthcare Stocks for 2016 (JNJ, PFE)

    December 8, 2015
    Discover the top five dividend health care stocks for 2016, including two pharmaceutical giants and two newer dividend stocks ...
  28. Why Biotech Affimed N.V. Should Be On Your Radar (JUNO, AFMD)

    December 8, 2015
    In the world of developmental biotech, picking the correct early stage companies can potentially make investors a fortune.
  29. If You Had Invested Right After Amgen's IPO (AMGN)

    November 30, 2015
    Discover how $1,000 invested in Amgen during its initial public offering (IPO), without reinvesting dividends, would be worth ...
  30. Amgen to Acquire Dezima Pharma for $1.55 Billion (AMGN)

    September 17, 2015
    Amgen (NASDAQ: AMGN) is placing a bet on a promising new medication. The company announced it has agreed to acquire Netherlands-based ...
  31. Key Financial Ratios to Analyze Biotech Companies (AMGN, GILD)

    August 20, 2015
    Explore the rapidly growing biotechnology industry, and learn some of the key financial ratios investors use to analyze companies ...
  32. Amgen Dazzles With a Duo of Fresh Data (AMGN)

    June 23, 2015
    Sometimes it appears as if a biotech stock can do no wrong, and for shareholders of biotech behemoth Amgen (NASDAQ: AMGN), ...
  33. Better Dividend Stock: Amgen or Gilead Sciences? (AMGN, GILD)

    June 19, 2015
    Dividend investors don't have very many investing options in the high-flying biotechnology industry, but of those choices, Amgen ...
  34. Is Amgen About to Enter a Battle Over Billions? (AMGN, REGN)

    June 15, 2015
    The Food and Drug Administration's key advisory committee has given the thumbs-up to two new drugs belonging to an entirely ...
  35. This Trial Could Be Worth Billions to Amgen (AMGN)

    June 10, 2015
    Amgen (NASDAQ: AMGN) will soon know whether European and U.S. regulators will give it the go-ahead to begin marketing its ...
  36. Is This Johnson & Johnson's Next Blockbuster? (JNJ, AMGN)

    June 10, 2015
    Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) may not be associated with high-growth biotech companies, but ...
  37. This Key Amgen Drug Is Setting a Precedent (AMGN, NVS)

    June 8, 2015
    Biotech blue-chip stock Amgen (NASDAQ: AMGN) has practically had its way with Wall Street over the last five years. While ...
  38. Amgen Takes a Hit, Shelves Potential Blockbuster (AMGN, AZN)

    May 29, 2015
    Amgen's (NASDAQ: AMGN) investors learned this past week that the company is walking away from its deal with AstraZeneca (NYSE: ...
  39. Amgen Gets 1 Step Closer to Another Blockbuster (AMGN, REGN)

    May 26, 2015
    A key European advisory committee has just thrown its support behind approval for Amgen's (NASDAQ: AMGN) Repatha, a new ...
  40. Amgen's Late-Stage Pipeline Clears Another Hurdle (AMGN)

    May 20, 2015
    The 2000s were practically a lost time for Amgen (NASDAQ: AMGN) investors, with the company producing predominantly low-to-mid ...
  41. 5 Things Amgen's Management Wants You to Know (AMGN)

    May 11, 2015
    With its share price already having tripled over the trailing four-year period, Amgen (NASDAQ: AMGN) delivered more solid ...
  42. A Quick Guide To Healthcare ETFs

    May 8, 2015
    The healthcare industry offers a broad variety of sector ETFs but it’s difficult to avoid exposure to pharmaceuticals and ...
  43. Amgen Earnings Preview: 5 Questions to Ask (AMGN)

    April 16, 2015
    In the biotechnology sector, few companies are more synonymous with innovation than Amgen (NASDAQ: AMGN). Throughout the ...
  44. Amgen's Most Surprising Success Is Its Dividend (AMGN)

    April 9, 2015
    As recently as four years ago, few dividend investors would ever have expected to see big payouts from the biotechnology ...
  45. Will This EU Approval Move the Needle for Amgen? (AMGN)

    April 6, 2015
    European regulators have announced that Amgen's (NASDAQ: AMGN) long-standing colorectal cancer drug Vectibix is OK for use ...
  46. Risks and Rewards of Biotech Companies

    April 1, 2015
    We look at the risks and rewards of investing in biotech companies.
  47. Amgen Hopes Kyprolis Can Become a Blockbuster (AMGN)

    April 1, 2015
    When Amgen (NASDAQ: AMGN) handed over $9.7 billion to acquire Onyx Pharmaceuticals in 2013, some investors worried that ...
  48. Amgen's Dividend Could Double in 5 Years (AMGN)

    March 30, 2015
    Amgen's (NASDAQ: AMGN) dividend yield of 1.9% may not look very enticing to investors looking for income today. But a close ...
  49. Why These Could Be 2015's 10 Best Biotech Stocks

    March 25, 2015
    A quick look at a 10 biotech companies that are poised to deliver for shareholders in 2015.
  50. Is This a Megablockbuster Drug in the Making? (AMGN)

    March 17, 2015
    Doctors may soon have another treatment option in their battle to control bad cholesterol levels. The FDA is scheduled in ...
  51. Could Amgen's Next Drug Be Worth $100 Billion?

    March 13, 2015
    Amgen hopes it will win an FDA green light for evolocumab, a next-generation cholesterol fighter, which could grab a big ...
  52. Why Celgene Won't Pay A Dividend Anytime Soon

    March 12, 2015
    The biotech sector has been virtually unstoppable over the past three years and has widely outperformed the broader market. ...
  53. What Is Amgen’s New Target?

    March 2, 2015
    Amgen's investors are focusing a lot on its cholesterol-busting drug evolocumab; however, their research into biosimilars ...
  54. The Biggest Biotech Companies

    January 15, 2015
    These biotech firms want to revolutionize medicine. If successful, they may see high profits, but investing in these companies ...
  55. How Amgen Makes Billions On Just A Few Drugs

    November 5, 2014
    Amgen produces relatively few drugs, but that's doesn't mean it's any less essential or profitable. Here's a look at the ...
  56. Who are Amgen Inc.'s (AMGN) main competitors?

    August 27, 2014
    Biotech giant Amgen (AMGN) list of competitors is lengthy and formidable. Learn the major companies Amgen competes with.
  57. 4 Large-Cap Healthcare Stocks To Watch

    August 18, 2014
    Healthcare continues to a be a hot sector. Here are four pharma stocks to keep an eye on for entry points.
  58. Interested In Healthcare Stocks? Look At This ETF

    July 3, 2014
    Healthcare companies seem to be poised to make a move higher over the months ahead. Here's an ETF that should be helpful ...
  59. What Are The Best Bets In Biotech?

    May 2, 2014
    The NASDAQ Biotechnology Index is off nearly 20% as its components busy themselves with hostile bids and frenzied buying ...
  60. 7 ETF Types To Be Thankful For

    November 28, 2013
    This year has shaped up to be quite kind to investors as major equity indexes are holding onto double-digit gains ahead of ...
  61. A Strong Prognosis For Healthcare Stocks

    November 19, 2013
    Despite the healthcare sectors recent torrid run, there’s still plenty to like about stocks in the industry. Aside from tailwinds ...
  62. Gilead Sciences Leads In Rising Short Interest Among Biotechs

    November 12, 2013
    Among leading biotech and emerging pharmaceutical companies, the number of shares sold short in Alexion Pharmaceuticals ...
  63. Alexion, Pharmacyclics Buck Trend in Biotech Short Interest (ALXN, ...

    September 14, 2013
    Declining short interest in Alexion Pharmaceuticals (NASDAQ: PCYC) bucked the trend among leading biotech and emerging pharmaceutical ...
  64. Amgen Sweetens The Bid And Secures Onyx

    August 26, 2013
    Amgen finalizes a value-additive deal for Onyx
  65. Can Sanofi Investors Just Blame It On Rio?

    August 6, 2013
    Can Sanofi Investors Just Blame It On Rio? By Stephen D. Simpson, CFA Sanofi (NYSE: SNY) was supposed to be a relatively ...
  66. Does Amgen Deserve To Be Part Of The Biotech Bull Run?

    July 31, 2013
    Amgen is beating growth targets today, but fears about generics and a dull pipeline concern investors.
  67. Wall Street Happy To Hum La AbbVie En Rose

    July 26, 2013
    AbbVie's pipeline is better than some think, but valuation is no particular bargain right now.
  68. Amgen Puts Onyx Pharmaceuticals In Play

    July 2, 2013
    An unsolicited $120/share bid has sent Onyx soaring and rival bidders circling.
  69. Short Interest in Biogen Idec and Vertex Shrinks (BIIB, CELG, ...

    June 26, 2013
    Among biotech and emerging pharmaceutical companies, Celgene (NASDAQ: CELG) and saw the most significant rise in short interest ...
  70. 10 Picks from 2 Strong Sectors

    June 10, 2013
    As we enter the bumpy summer months, large-cap US domestic stocks and health-care names are on Louis Navellier's list, and ...
  71. Alnylam Basking In Orphan Drug Attention

    May 28, 2013
    Alnylam has already seen a big run, but clinical success could bring even more gains.
  72. Amgen Chased By The Bubble

    May 8, 2013
    Amgen really needs the pipeline to come through to support this valuation.
  73. Teva Likely To Tread Water Ahead Of New Strategy

    November 5, 2012
    Teva has restructuring and growth opportunities, but the risk is still elevated.
  74. Amgen and Other Healthcare Stocks Making Big Moves on October ...

    October 19, 2012
    The market is having a bad day so far: the Nasdaq has slipped 1.6%; the S&P 500 is trading down 1%; and the Dow is down ...
  75. It's Time to Sell These 4 Surging Stocks

    October 19, 2012
    With the S&P 500 surging roughly 25% in the past 12 months, it's been a great time to have full exposure to the stock ...
  76. The Week In Healthcare

    August 31, 2012
    Although this has been a solid year for med-tech, some sub-sectors are starting to lag a bit during this late summer rally.
  77. Portfolio Pruning 101

    July 27, 2012
    MoneyShow's Tom Aspray takes an in-depth look at his successful Charts in Play Portfolio, as he looks to take profits on ...
  78. Healthcare Stocks Continuing To Outperform

    July 18, 2012
    These healthcare stocks are still on fire, with potentially more upside left. But is that actually bad for the stock market?
  79. ilent Pays A Hefty Price For A Fixer-Upper Diagnostics Company

    May 22, 2012
    Agilent is paying up to get into the increasingly crowded diagnostics market.
  80. Biotech ETFs Hitting Highs

    May 17, 2012
    Biotech ETFs are hitting all-time highs and XBI looks like the best of the group. Because the ETF is already up 25% in 2 ...
  81. AstraZeneca Searches For Answers

    May 3, 2012
    AstraZeneca has an opportunity to do something big when it brings in a new CEO.
  82. 4 ETFs On Fire Right Now

    February 3, 2012
    The commodities market had some of the best-performing ETFs of January.
  83. Big Buys In Share Buybacks

    January 27, 2012
    Record corporate profits and super low interest rates are resulting in a shrinking market environment and a rise in share ...
  84. Be Your Own Venture Capitalist With These Stocks

    September 16, 2011
    By doing some digging, there are ways for the average joe to become his/her own venture capital fund.
  85. A Deal At Last For Sanofi And Genzyme

    February 18, 2011
    Though Sanofi finally got its way in acquiring Genzyme, time will determine if stockholders will truly benefit.
  86. Top-Heavy Pharmaceuticals

    August 27, 2010
    Investors should keep an eye on how much drug companies rely on its top sellers.
  87. Getting In On Growth At A Great Price

    July 5, 2010
    Here are some growth-oriented stocks with below-market average P/Es that investors can pick up during this shaky market to ...
  88. Biotech Bargains

    June 17, 2010
    High-growth biotech stocks are now priced like value plays.
  89. The 5 Most Important Drugs In America

    July 28, 2009
    A look at the top-selling drugs finds that a few that make more of a difference to the company's bottom line than others.
  90. Two More Reasons To Diversify

    June 3, 2009
    GM and Citigroup being removed from the DJIA should cause investors to focus on diversification.
  91. Convertible Securities In Today's Market

    April 30, 2009
    John Calamos, the father of convertible investing, moderated a panel on convertible bonds at the Milken Global Conference ...
  92. Dark Horse Candidates To Enter The Dow

    March 4, 2009
    The DJIA is sure to be rebalanced over the next year as some members teeter on bankruptcy or face falling from the index.
  93. Buyer Beware In Biotech ETFs

    August 27, 2007
    The biotech sector has been flat this year, and the five biotech ETFs have been hit and miss - mainly miss.
  94. Up on Amgen (AMGN)

    April 30, 2007
    Amgen shares are in a rut, and that could signal opportunity for investors.
Trading Center